Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10391361

Download in:

View as

General Info

PMID
10391361